With Hologic, Inc. HOLX gearing up to release its fiscal 2025 first-quarter financial results on Feb. 5 after the market ...

Shares of Hologic Inc. HOLX shed 1.35% to $71.77 Tuesday, on what proved to be an all-around favorable trading session for ...

Hologic HOLX is set to release first-quarter fiscal 2025 results on Feb. 5 after the closing bell. Stay up-to-date with all ...

This was the stock's second consecutive day of gains.

The Hologic Women’s Health Index’s 2023 data found a decrease in testing for any cancer among women — a first in the survey’s ...

Hologic Inc (HOLX) stock saw a modest uptick, ending the day at $71.02 which represents a slight increase of $0.32 or 0.45% from the prior close of $70.7. The stock opened at $70.45 and touched a low ...

Hologic Inc (HOLX) stock saw a decline, ending the day at $70.7 which represents a decrease of $-0.49 or -0.69% from the prior close of $71.19. The stock opened at $71.42 and touched a low of $69.87 ...

Investment analysts at Leerink Partnrs lowered their Q2 2025 EPS estimates for shares of Hologic in a research note issued on ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Leerink Partners analyst Puneet Souda maintained a Buy rating on Hologic (HOLX – Research Report) yesterday and set a price target of $80.00.

Elina Svitolina, Emma Raducanu, Maria Sakkari and Karolina Muchova are just a few of the names who will headline indoor ...

Women’s cancer testing has declined globally, according to the latest Hologic Global Women’s Health Index, one of the largest collections of data on women’s health and well-being. This press release ...